RecruitingNot ApplicableNCT06058650

Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

Pilot Clinical Study to Evaluate Molecular Breast Imaging- Guidance for Sampling of Breast Abnormalities

Sponsor

Mayo Clinic

Enrollment

70 participants

Start Date

Aug 26, 2021

Study Type

INTERVENTIONAL

Conditions

Breast Neoplasm

Summary

This clinical trial tests how well molecular breast imaging (MBI) works to guide the collection of a breast biopsy in patients with a breast abnormality. Currently, a biopsy is often guided by either ultrasound or mammography in order to ensure that a sample of the correct part of the breast is taken. Sometimes a lesion or part of the lesion cannot be seen on ultrasound or mammography, and, therefore, a biopsy guided with ultrasound or mammography may not be always be accurate. Studies have shown that high resolution MBI may have potential to improve the detection of some breast tumors. This trial uses a new high-resolution MBI system that may help perform a biopsy using MBI.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new imaging-guided biopsy method for the breast. Instead of using standard mammography or MRI to guide the needle biopsy, doctors use a special nuclear medicine scan called Molecular Breast Imaging (MBI) to find and sample suspicious areas. **You may be eligible if...** - You are a woman aged 18 or older - You had an MBI scan within the last 3 years that found a suspicious area, which was later confirmed to be benign (non-cancerous) - You are not pregnant (a pregnancy test within 48 hours before the procedure is required if you could become pregnant) - You have agreed to participate in the study **You may NOT be eligible if...** - You are pregnant or could be pregnant and have not had a recent negative test Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.